Clinical presentations and molecular studies of invasive renal epithelioid angiomyolipoma
- 25 May 2017
- journal article
- case report
- Published by Springer Science and Business Media LLC in International Urology and Nephrology
- Vol. 49 (9), 1527-1536
- https://doi.org/10.1007/s11255-017-1629-4
Abstract
Purpose Epithelioid angiomyolipoma (EAML) is a rare variant of renal angiomyolipoma with malignant potential, and the cytogenetic and clinical behavior of EAML remains a challenging issue. Methods We retrospectively analyze the clinical courses of five EAML, the use of everolimus on metastatic EAML, and next-generation sequencing (NGS) and polymerase chain reaction (PCR) studies to investigate the gene mutation of TSC and the impact of PI3K/Akt/mTOR signaling pathway in metastatic EAML. Results The mean age was 37.8 years, mean tumor size was 13 cm, all patients received radical nephrectomy, one stage IV patient received neoadjuvant mTOR inhibitor management, and one patient with high mitotic activity developed metastasis 1 year after nephrectomy. NGS assay showed a frameshift gene mutation of TSC2 in chromosome 16. PCR array for the mRNA alterations in PI3K/Akt/mTOR signaling pathway of EAML showed high expression of PIP3, AKT, TSC1, mTOR, PDK1, P70, 4E-BP1 and elF4E. Conclusion EAML of the kidney is a specific type of renal AML with malignant potentials, where around 22% of the patients present with invasion or metastasis. Higher mitotic activities indicate a greater metastatic potential, with radical nephrectomy as the treatment of choice, and mTOR inhibitors such as everolimus either as neoadjuvant or adjuvant targeted therapy can lead to a better clinical outcome. NGS to explore the mTOR signaling pathway may help us to better understand the pathogenesis and progression of EAML.Keywords
Funding Information
- National Science Council of Taiwan (NSC 105-2314-B-182-024-MY3)
- Chang Gung Memorial Hospital for financial aid (CMRPG1A0051-2, CMRPG3A0811-3)
This publication has 29 references indexed in Scilit:
- Dramatic Tumor Response to Everolimus for Malignant Epithelioid AngiomyolipomaJapanese Journal of Clinical Oncology, 2011
- Pure Epithelioid PEComas (So-Called Epithelioid Angiomyolipoma) of the KidneyThe American Journal of Surgical Pathology, 2011
- Renal Epithelioid Angiomyolipoma With Atypia: A Series of 40 Cases With Emphasis on Clinicopathologic Prognostic Indicators of MalignancyThe American Journal of Surgical Pathology, 2010
- The Efficacy and Outcomes of Urgent Superselective Transcatheter Arterial Embolization of Patients With Ruptured Renal AngiomyolipomasThe Journal of Trauma and Acute Care Surgery, 2007
- Protein Expression Profiles in Renal Cell Carcinoma: Staging, Prognosis, and Patient Selection for Clinical TrialsClinical Cancer Research, 2007
- The Role of Tuberin in Cellular Differentiation: Are B‐Raf and MAPK Involved?Annals of the New York Academy of Sciences, 2005
- TSC2 regulates VEGF through mTOR-dependent and -independent pathwaysCancer Cell, 2003
- Renal Angiomyolipoma With Epithelioid Sarcomatous Transformation and MetastasesThe American Journal of Surgical Pathology, 2000
- Loss of heterozygosity in tuberous sclerosis hamartomas.Journal of Medical Genetics, 1996
- Identification and characterization of the tuberous sclerosis gene on chromosome 16Cell, 1993